Status:
COMPLETED
Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application
Lead Sponsor:
Sonova AG
Conditions:
Hearing Loss
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
A methodical evaluation of novel sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired. These soun...
Eligibility Criteria
Inclusion
- Adult hearing impaired persons (minimum age: 18 years) with and without experience with) hearing aids
- Healthy outer ear (without previous surgical procedures)
- Ability to fill in a questionnaire conscientiously
- Informed Consent as documented by signature
Exclusion
- Contraindications to the medical device in this study, e.g. known hypersensitivity or allergy to the investigational product
- Limited mobility and not in the position to attend weekly appointments
- Limited ability to describe listening impressions/experiences and the use of the hearing aid
- Inability to produce a reliable hearing test result
- Massively limited dexterity
- Known psychological problems
- Known central hearing disorders
Key Trial Info
Start Date :
December 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03780374
Start Date
December 3 2018
End Date
March 15 2019
Last Update
May 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sonova AG
Stäfa, Canton of Zurich, Switzerland, 8712